Acciones Nunzia Pharmaceutical Corporation Other OTC
Acciones
NUNZ
US67097W1027
Farmacéuticos
Ventas 2020 | - | Ventas 2021 | - | Capitalización | 170 M 158 M |
---|---|---|---|---|---|
Resultado Neto 2020 | -9 M -8,36 M | Resultado Neto 2021 | -78 M -72,43 M | VE / Ventas 2020 | - |
Posición de caja neta 2020 * | - 0 | Deuda neta 2021 | 97,31 mil 90,36 mil | VE / Ventas 2021 | - |
P/E ratio 2020 |
-94,8
x | P/E ratio 2021 |
-2,54
x | Empleados | - |
Rendimiento 2020 * |
-
| Rendimiento 2021 |
-
| Flotante | 18,04 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
President | 68 | 01/01/09 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 05/12/19 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
President | 68 | 01/01/09 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 05/12/19 |
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
+31,52 % | 662 mil M | |
+21,96 % | 546 mil M | |
-5,21 % | 359 mil M | |
+17,02 % | 323 mil M | |
+5,01 % | 289 mil M | |
+13,68 % | 234 mil M | |
+3,81 % | 198 mil M | |
-10,63 % | 194 mil M | |
+3,98 % | 167 mil M |